Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?

Andrea Giannini¹, Giorgio Bogani², Enrico Vizza³, Vito Chiantera⁴, Antonio Simone Laganà⁴, Ludovico Muzii², Maria Giovanna Salerno⁵, Donatella Caserta⁶, Ottavia D'Oria¹

Affiliations

¹ Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University, 00189 Rome, Italy.
² Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, 00185 Rome, Italy.
³ Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCSS-Regina Elena National Cancer Institute, 00144 Rome, Italy.
⁴ Unit of Gynecologic Oncology, ARNAS "Civico-Di Cristina-Benfratelli", Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
⁵ Obstetrics and Gynecological Unit, Department of Woman's and Child's Health, San Camillo-Forlanini Hospital, 00152 Rome, Italy.
⁶ Gynecology Division, Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.

PMID: 36141217
PMCID: PMC9498501
DOI: 10.3390/healthcare10091605

Editorial

Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?

Andrea Giannini et al. Healthcare (Basel). 2022.

. 2022 Aug 24;10(9):1605.

doi: 10.3390/healthcare10091605.

Authors

Andrea Giannini¹, Giorgio Bogani², Enrico Vizza³, Vito Chiantera⁴, Antonio Simone Laganà⁴, Ludovico Muzii², Maria Giovanna Salerno⁵, Donatella Caserta⁶, Ottavia D'Oria¹

Affiliations

¹ Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University, 00189 Rome, Italy.
² Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, 00185 Rome, Italy.
³ Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCSS-Regina Elena National Cancer Institute, 00144 Rome, Italy.
⁴ Unit of Gynecologic Oncology, ARNAS "Civico-Di Cristina-Benfratelli", Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
⁵ Obstetrics and Gynecological Unit, Department of Woman's and Child's Health, San Camillo-Forlanini Hospital, 00152 Rome, Italy.
⁶ Gynecology Division, Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.

PMID: 36141217
PMCID: PMC9498501
DOI: 10.3390/healthcare10091605

Abstract

According to 2020 comprehensive global cancer statistics published by the International Agency for Research on Cancer, gynecologic malignancies accounted overall for 16 [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
1. Makker V., Colombo N., Casado Herráez A., Santin A.D., Colomba E., Miller D.S., Fujiwara K., Pignata S., Baron-Hay S., Ray-Coquard I., et al. Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer. N. Engl. J. Med. 2022;386:437–448. doi: 10.1056/NEJMoa2108330. - DOI - PMC - PubMed
1. Colombo N., Dubot C., Lorusso D., Caceres M.V., Hasegawa K., Shapira-Frommer R., Tewari K.S., Salman P., Hoyos Usta E., Yañez E., et al. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer. N. Engl. J. Med. 2021;385:1856–1867. doi: 10.1056/NEJMoa2112435. - DOI - PubMed
1. Ray-Coquard I., Pautier P., Pignata S., Pérol D., González-Martín A., Berger R., Fujiwara K., Vergote I., Colombo N., Mäenpää J., et al. Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer. N. Engl. J. Med. 2019;381:2416–2428. doi: 10.1056/NEJMoa1911361. - DOI - PubMed
1. Di Tucci C., Schiavi M.C., Faiano P., D’Oria O., Prata G., Sciuga V., Giannini A., Palaia I., Muzii L., Panici P.B. Therapeutic Vaccines and Immune Checkpoints Inhibition Options for Gynecological Cancers. Crit. Rev. Oncol./Hematol. 2018;128:30–42. doi: 10.1016/j.critrevonc.2018.05.011. - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?

Affiliations

Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

LinkOut - more resources

Full Text Sources